Abnormalities of hypothalamic-pituitary-adrenal and hypothalamic- somatotrophic axes in Fawn-Hooded rats

European Journal of Endocrinology

Volumn 141, Issue 3, 1999, Pages 290-296

  Gómez, Francisca ^a   Graugés, Pilar ^a   López Calderón, Asunción ^b   Armario, Antonio ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; MESSENGER RNA; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; GENE EXPRESSION; HIPPOCAMPUS; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DNA PROBES; GENE EXPRESSION REGULATION; GROWTH HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNORADIOMETRIC ASSAY; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR I; MALE; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; SEROTONIN; TRANSCORTIN;

EID: 17944397238     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1410290     Document Type: Article

References (49)

1. Tschopp TB & Zucker MB. Hereditary defect in platelet function in rats. Blood 1972 40 217-226.
2. Provoost AP & De Keijzer MH. The Fawn-Hooded rat: a model for chronic renal failure. In Experimental and Genetic Rat Models of Chronic Renal Failure, pp 100-114. Eds N Gretz & M Strauch. Basel: Karger, 1993.
3. Pryor JC & Sulser F. Evolution of the monoamine hypotheses of depression. In Biological Aspects of Affective Disorders, pp 77-94. Eds RW Horton & CLE Katona. London: Academic Press, 1991.
4. Arora RC, Tong C, Jackman HL, Stoff D & Meltzer HY. Serotonin uptake and imipramine binding in blood platelets and brain of Fawn-Hooded and Sprague-Dawley rats. Life Sciences 1983 33 437-442.
5. 3H]imipramine binding in platelets and cerebral cortex of Fawn-Hooded rats. European Journal of Pharmacology 1981 72 137-138.
6. 3H]imipramine binding sites in brains of male and female Fawn-Hooded and Long-Evans rats. European Journal of Pharmacology 1985 112 261-264.
7. Aulakh CS, Wozniak KM, Hill JL, Devane CL, Tolliver TJ & Murphy DL. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Neuroendocrinology 1988 48 401-406.
8. Wang P, Aulakh CS, Hill JL & Murphy DL. Fawn hooded rats are subsensitive to the food intake suppressant effects of 5-HT agonists. Psychopharmacology 1988 94 558-562.
9. 2 adrenergic hetero-receptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain. Journal of Pharmacology and Experimental Therapeutics 1992 262 1038-1043.
10. Aulakh CS, Hill JL & Murphy DL. Attenuation of hypercortisolemia in Fawn-Hooded rats by antidepressant drugs. European Journal of Pharmacology 1993 240 85-88.
11. Altemus M, Smith MA, Diep V, Aulakh CS & Murphy DL. Increased mRNA for corticotropin releasing hormone in the amygdala of Fawn-Hooded rats: a potential animal model of anxiety. Anxiety 1994/1995 1 251-257.
12. Lahmame A, Gómez F & Armario A. Fawn-Hooded rats show enhanced active behaviour in the forced swimming test, with no evidence for pituitary-adrenal axis hyperactivity. Psychopharmacology 1996 125 74-78.
13. Solt RD. Behavioral despair. In Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives, pp 121-138. Eds SJ Enna et al. New York: Raven Press, 1981.
14. Borsini F & Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 1988 94 147-160.
15. Overstreet DH & Rezvani AH. Behavioral differences between two inbred strains of Fawn-Hooded rat: a model of serotonin dysfunction. Psychopharmacology 1996 128 328-330.
16. Müller EE. Neural control of somatrotopic function. Physiological Reviews 1987 67 962-1053.
17. Van de Kar LD. Neuroendocrine pharmacology of serotoninergic (5-HT) neurons. Annual Review of Pharmacology and Toxicology 1991 31 289-320.
18. Haack D, Möhring J, Möhring C, Petri M & Hackenthal E. Comparative study on development of corticosterone and DOCA hypertension in rats. American Journal of Physiology 1977 233 F403-F411.
19. Bohus B & Koolhaas JM. Stress and the cardiovascular system: central and peripheral physiological mechanisms. In Stress From Synapse to Syndrome, pp 76-119. Eds SC Stanford & P Salmon. London: Academic Press, 1993.
20. Phillips LS & Young HS. Nutrition and somatomedin I. Effect of fasting and refeed on serum somatomedin activity and cartilage growth activity in rats. Endocrinology 1976 99 304-314.
21. Tannenbaum GS, Epelbaum J, Colle E, Brazeau P & Martin JB. Antiserum to somatostatin reverses starvation-induced inhibition of growth hormone but not insulin secretion. Endocrinology 1978 102 1909-1914.
22. Brook CGD, Hindmarsh PC & Stanhope R. Growth and growth hormone secretion. Journal of Endocrinology 1988 119 179-184.
23. Straus DS. Nutritional regulation of hormones and growth factors that control mammalian growth. FASEB Journal 1994 8 6-12.
24. Rivier C & Vale W. Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology 1984 114 2406-2411.
25. Rivier C & Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology 1985 117 2478-2482.
26. Giustina A & Wehrenberg WB. The role of glucocorticoids in the regulation of growth hormone secretion. Trends in Endocrinology and Metabolism 1992 3 306-311.
27. Thakore JH & Dinan TG. Growth hormone secretion: the role of glucocorticoids. Life Sciences 1994 55 1083-1099.
28. Armario A & Castellanos JM. A simple procedure for direct corticosterone radioimmunoassay in the rat. Revista Española Fisiologia 1984 40 437-442.
29. Daughaday WH, Mariz IK & Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. Journal of Clinical Endocrinology and Metabolism 1980 51 781-788.
30. DiMarchi R, Long H, Epp J, Schoner B & Belagaje R. Synthesis of insulin-like growth factor I through recombinant DNA techniques and selective chemical cleavaje at tryptophan. In Synthetic Peptides: Approaches to Biological Problems, vol 86, pp 283-294. Eds JP Tam, ET Kaiser. UCLA Symposia on Molecular and Cellular Biology New Series. New York: Ala R Liss Inc., 1989.
31. DiMarchi R, Long H, Epp J, Schoner B & Belagaje R. Biosynthesis and characterization of insulin-like growth factor I (IGF-I). In Peptides, Chemistry, Structure and Biology. Proceedings of the Eleventh American Peptide Symposium, pp 99-100. Eds JE Rivier & GR Marshall. Leiden: ESCOM, 1990.
32. Paxinos G & Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. London: Academic Press, 1986.
33. Miesfeld R, Rusconi S, Godowski PJ, Maler BA, Okret S, Wikstrom A-C et al. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 1986 46 389-399.
34. Gómez F Lahmame A, De Kloet ER & Armario A. Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996 63 327-337.
35. Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ & Kuhn RW. The serum transport of steroid hormones. Recent Progress in Hormone Research 1982 38 457-510.
36. Gruen PH. Endocrine changes in psychiatric diseases. Medical Clinics of North America 1978 62 285-296.
37. Davis M. The role of the amygdala in fear and anxiety. Annual Review of Neuroscience 1992 15 353-375.
38. Swiergiel AH. Takahashi LK & Kalin HH. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Research 1993 623 229-234.
39. Wiersma A, Bohus B & Koolhaas JM. Corticotropin-releasing hormone microinfusion in the central amygdala diminishes a cardiac parasympathetic outflow under stress-free conditions. Brain Research 1993 625 219-227.
40. Kalin NH, Takahashi LK & Chen F-L. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Research 1994 656 182-186.
41. Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. Journal of Neuroscience 1995 15 5439-5447.
42. Holly JMP & Wass JAH. Insulin-like growth factors: autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. Journal of Endocrinology 1989 122 611-618.
43. Berelowitz M, Firestone SL & Frohman LA. Effects of growth hormone excess and deficiency on hypothalamic somatostatin distribution. Endocrinology 1981 109 714-719.
44. Berelowitz M, Szabo M, Frohman LA, Firestone SL & Chu L. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 1981 212 1279-1281.
45. Tannenbaum GS, Guyda HJ & Posner BI. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 1983 229 77-79.
46. Rogers KV, Vician L, Steiner RA & Clifton DK. The effect of hypophysectomy and growth hormone administration on preprosomatostatin messenger ribonucleic acid in the periventricular nucleus of the rat hypothalamus. Endocrinology 1988 122 586-591.
47. Bertherat J, Timsit J, Bluet-Pajot MT, Mercadier JJ, Gourdji D, Kordon C et al. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat. Journal of Clinical Investigation 1993 91 1783-1791.
48. Pellegrini E, Bluet-Pajot MT, Mounier F, Bennett P, Kordon C & Epelbaum J. Central administration of a growth hormone (GH) receptor mRNA antisense increases GH pulsatility and decreases hypothalamic somatostatin expression in rats. Journal of Neuroscience 1996 16 8140-8148.
49. Graeff FG. Role of 5-HT in defensive behavior and anxiety. Reviews in the Neurosciences 1993 4 181-211.